Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan

Japanese Journal of Ophthalmology

Volumn 43, Issue 2, 1999, Pages 133-138

  Wakakura, Masato ^a   Mashimo, Kimiyo ^a   Oono, Shinji ^b   Matsui, Yoshie ^b   Tabuchi, Akio ^c   Kani, Kazutaka ^d   Shikishima, Keigo ^e   Kawai, Kazushige ^e   Nakao, Yuzo ^f   Tazawa, Yutaka ^g   Kiyosawa, Motohiro ^h   Abe, Haruki ⁱ   Ohba, Norio ^j   Yago, Keiko ^k   Maeda, Shuji ^l   Sugita, Minoru ^m   Ishikawa, Satoshi ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g IWATE MEDICAL UNIVERSITY   (Japan)

^h TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

ⁱ NIIGATA UNIVERSITY   (Japan)

^j KAGOSHIMA UNIVERSITY   (Japan)

^k FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^l HIROSAKI UNIVERSITY   (Japan)

^m TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Corticosteroid; Multicenter treatment trial; Multiple sclerosis; Optic neuritis; Pulse treatment

Indexed keywords

MECOBALAMIN; METHYLPREDNISOLONE;

ACNE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIARRHEA; DRUG EFFICACY; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VISUAL ACUITY;

ADOLESCENT; ADULT; COLOR PERCEPTION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; JAPAN; MALE; METHYLPREDNISOLONE; MIDDLE AGED; OPTIC NEURITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS; VITAMIN B 12;

EID: 0032907971     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(98)00071-9     Document Type: Article

References (18)

1. Wakakura M., Okano T., Yamada T. A retrospective evaluation of non-steroid and pulse therapy on idiopathic optic neuritis. Shinkeiganka (Neuro-ophthalmology Japan). 7:1990;368-372.
2. Wakakura M., Ishikawa S., Oono S.et al. Incidence of acute idiopathic optic neuritis and its therapy in Japan. Nippon Ganka Gakkai Zasshi (J Jpn Ophthalmol Soc). 99:1995;93-97.
3. Perkin G.D., Rose F.C. Optic neuritis and its differential diagnosis. 1979;Oxford University Press, Oxford.
4. Beck R.W., Cleary P.A., Anderson M.M. Jr. et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Eng J Med. 326:1992;581-588.
5. Wakakura M., Minei R., Oono S.et al. Baseline profile of idiopathic optic neuritis in the multicenter treatment trial in Japan. Jpn J Ophthalmol. 43:1999;127-132.
6. ONMRG. Optic neuritis multicenter treatment trial in Japan. Shinkeiganka (Neuro-ophthalmology Japan) 1991;8:55-8.
7. Ginsburg A.P. A new contrast sensitivity vision test chart. Am J Optom Physiol Opt. 61:1984;403-407.
8. Ootori T., Nakao Y., Toma N., Manabe R. Clinical evaluation of usefulness of determination of central critical flicker frequency in ocular diseases. Rinsho Ganka (Jpn J Clin Ophthalmol). 27:1973;301-310.
9. Woung L., Wakakura M., Ishikawa S. Critical flicker frequency in acute and recovered optic neuritis. Jpn J Ophthalmol. 37:1993;122-129.
10. Trauzettel-Klosinski S., Diener H.-C., Dietz K., Zrenner E. The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study. Doc Ophthalmol. 91:1996;165-179.
11. Beck RW, Cleary PA, The Optic Neuritis Study Group. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993;111:773-5.
12. 12 improves cognitive disturbance in rodents fed a choline-deficient diet. Pharmacol Biochem Behav. 43:1992;635-639.
13. 12 analog, against gluamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci. 38:1997;848-854.
14. Livingstone M.S., Hubel D.H. Psychophysical evidence for separate channels for the perception of form, color, movement and depth. J Neurosci. 7:1987;3416-3468.
15. Keltner JL, Johnson CA, Spurr JO, Beck RW, The Optic Neuritis Study Group. Visual field profile of optic neuritis. One-year follow-up in the optic neuritis treatment trial. Arch Ophthalmol 1994;112:946-53.
16. Trobe J.D. High-dose corticosteroid regimen retards development of multiple sclerosis in optic neuritis treatment trial. Arch Ophthalmol. 112:1994;35-36.
17. Beck R.W., Cleary P.A., Trobe J.D.et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 329:1993;1764-1769.
18. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology 1997;49:1404-13.